HEADER COMPLEX (SERINE PROTEASE/INHIBITOR) 31-JAN-96 1VIT TITLE THROMBIN:HIRUDIN 51-65 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPSILON THROMBIN; COMPND 3 CHAIN: L, M; COMPND 4 EC: 3.4.21.5; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ALPHA THROMBIN; COMPND 7 CHAIN: H; COMPND 8 EC: 3.4.21.5; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: HIRUDIN; COMPND 11 CHAIN: I, J; COMPND 12 FRAGMENT: RESIDUES 51 - 65; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 4; COMPND 15 MOLECULE: EPSILON THROMBIN; COMPND 16 CHAIN: F; COMPND 17 EC: 3.4.21.5; COMPND 18 MOL_ID: 5; COMPND 19 MOLECULE: EPSILON THROMBIN; COMPND 20 CHAIN: G; COMPND 21 EC: 3.4.21.5 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 ORGAN: BLOOD; SOURCE 6 TISSUE: BLOOD; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 9 ORGANISM_COMMON: CATTLE; SOURCE 10 ORGANISM_TAXID: 9913; SOURCE 11 ORGAN: BLOOD; SOURCE 12 TISSUE: BLOOD; SOURCE 13 MOL_ID: 3; SOURCE 14 MOL_ID: 4; SOURCE 15 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 16 ORGANISM_COMMON: CATTLE; SOURCE 17 ORGANISM_TAXID: 9913; SOURCE 18 ORGAN: BLOOD; SOURCE 19 TISSUE: BLOOD; SOURCE 20 MOL_ID: 5; SOURCE 21 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 22 ORGANISM_COMMON: CATTLE; SOURCE 23 ORGANISM_TAXID: 9913; SOURCE 24 ORGAN: BLOOD; SOURCE 25 TISSUE: BLOOD KEYWDS COMPLEX (SERINE PROTEASE-INHIBITOR), HYDROLASE, SERINE PROTEASE, KEYWDS 2 BLOOD COAGULATION, COMPLEX (SERINE PROTEASE-INHIBITOR) COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.VITALI,B.F.P.EDWARDS REVDAT 5 03-APR-24 1VIT 1 HETSYN REVDAT 4 29-JUL-20 1VIT 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 13-JUL-11 1VIT 1 VERSN REVDAT 2 24-FEB-09 1VIT 1 VERSN REVDAT 1 21-APR-97 1VIT 0 JRNL AUTH J.VITALI,P.D.MARTIN,M.G.MALKOWSKI,C.M.OLSEN,P.H.JOHNSON, JRNL AUTH 2 B.F.EDWARDS JRNL TITL STRUCTURE OF A BOVINE THROMBIN-HIRUDIN51-65 COMPLEX JRNL TITL 2 DETERMINED BY A COMBINATION OF MOLECULAR REPLACEMENT AND JRNL TITL 3 GRAPHICS. INCORPORATION OF KNOWN STRUCTURAL INFORMATION IN JRNL TITL 4 MOLECULAR REPLACEMENT. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 52 453 1996 JRNL REFN ISSN 0907-4449 JRNL PMID 15299666 JRNL DOI 10.1107/S0907444996000364 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 69.8 REMARK 3 NUMBER OF REFLECTIONS : 8659 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5029 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : 0.50 REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.500 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 RESIDUES 51, 54, 62, 64, AND 65 OF PEPTIDE 1 HAVE POOR REMARK 3 DENSITY. MOST OF PEPTIDE 2 IS EFFECTIVELY DISORDERED WITH REMARK 3 RESIDUES 53, 54, 58, 59, 60, 61, 64, 65 HAVING POOR REMARK 3 DENSITY. EXCEPT FOR A FEW RESIDUES, THE TWO THROMBINS ARE REMARK 3 GENERALLY WELL DEFINED IN THE ELECTRON DENSITY MAPS FOR REMARK 3 RESIDUES 1C - 14K AND 16 - 243. REMARK 4 REMARK 4 1VIT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000177052. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 295 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XENGEN REMARK 200 DATA SCALING SOFTWARE : XENGEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11300 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.0 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12600 REMARK 200 FOR THE DATA SET : 7.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 41.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT AND REMARK 200 GRAPHICS REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: BOVINE THROMBIN IN COMPLEX WITH HIRUDIN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP, RESERVOIRS CONTAINING REMARK 280 39% SATURATED AMMONIUM SULFATE, 0.25 M AMMONIUM PHOSPHATE PH 8.0 REMARK 280 AND 1% PEG4000. DROPS CONSISTED OF EQUAL VOLUMES OF RESERVOIR REMARK 280 AND PROTEIN SOLUTION CONTAINING 23.5 MG/ML PROTEIN., VAPOR REMARK 280 DIFFUSION - HANGING DROP, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.86667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 133.73333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 100.30000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 167.16667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.43333 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 66.86667 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 133.73333 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 167.16667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 100.30000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 33.43333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE TWO COMPLEXES PER ASYMMETRIC UNIT. EACH COMPLEX REMARK 300 CONSISTS OF ONE MOLECULE OF THROMBIN AND ONE MOLECULE OF REMARK 300 HIRUDIN 51 - 65. THROMBIN IN COMPLEX 1 IS ALPHA-THROMBIN REMARK 300 AND IS CLEAVED BETWEEN RESIDUES 15 AND 16. CHAIN INDICATOR REMARK 300 *L* IS USED FOR RESIDUES 1H - 15, CHAIN INDICATOR *H* IS REMARK 300 CHAIN INDICATOR *H* IS USED FOR RESIDUES 16 - 246, AND REMARK 300 CHAIN INDICATOR *I* IS USED FOR THE PEPTIDE. THROMBIN IN REMARK 300 COMPLEX 2 IS EPSILON THROMBIN AND, IN ADDITION TO THE CUT REMARK 300 BETWEEN RESIDUES 15 AND 16, IT IS ALSO CLEAVED BETWEEN REMARK 300 RESIDUES 149A AND 149B. CHAIN INDICATORS IN COMPLEX 2 ARE REMARK 300 *M* FOR RESIDUES 1H - 15, *F* FOR RESIDUES 15 - 149A, *G* REMARK 300 FOR RESIDUES 149B - 247, AND *J* FOR THE PEPTIDE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, I, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -65.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: M, F, G, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR L 1U REMARK 465 SER L 1T REMARK 465 GLU L 1S REMARK 465 ASP L 1R REMARK 465 HIS L 1Q REMARK 465 PHE L 1P REMARK 465 GLN L 1O REMARK 465 PRO L 1N REMARK 465 PHE L 1M REMARK 465 PHE L 1L REMARK 465 ASN L 1K REMARK 465 GLU L 1J REMARK 465 LYS L 1I REMARK 465 THR M 1U REMARK 465 SER M 1T REMARK 465 GLU M 1S REMARK 465 ASP M 1R REMARK 465 HIS M 1Q REMARK 465 PHE M 1P REMARK 465 GLN M 1O REMARK 465 PRO M 1N REMARK 465 PHE M 1M REMARK 465 PHE M 1L REMARK 465 ASN M 1K REMARK 465 GLU M 1J REMARK 465 LYS M 1I REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY I 54 N - CA - C ANGL. DEV. = -20.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU L 1C -60.84 -8.32 REMARK 500 ALA L 1B 34.65 -151.79 REMARK 500 PHE L 7 -86.38 -137.24 REMARK 500 GLN L 11 7.13 56.90 REMARK 500 ILE L 14K -58.68 64.75 REMARK 500 GLU L 14L 108.81 -59.41 REMARK 500 PRO H 28 -4.16 -59.80 REMARK 500 ALA H 56 -19.28 -48.44 REMARK 500 ASP H 60E 19.07 49.36 REMARK 500 ASN H 60G 83.53 -173.72 REMARK 500 ARG H 77A -50.28 -29.15 REMARK 500 ASP H 86 -76.46 -120.22 REMARK 500 ASN H 98 17.41 -175.77 REMARK 500 ARG H 110 119.85 -177.26 REMARK 500 PRO H 120 158.77 -48.23 REMARK 500 ASN H 143 134.81 -38.13 REMARK 500 TRP H 148 -87.86 -91.46 REMARK 500 THR H 149A -159.26 -53.26 REMARK 500 SER H 149B 157.12 82.90 REMARK 500 ALA H 149D 23.63 -162.57 REMARK 500 GLU H 149E 41.78 82.02 REMARK 500 SER H 171 -33.23 -157.58 REMARK 500 ARG H 175 102.61 -59.83 REMARK 500 ARG H 187 -162.73 -117.65 REMARK 500 ASP H 189 162.31 164.83 REMARK 500 CYS H 191 -160.61 -126.48 REMARK 500 VAL H 213 94.48 -44.03 REMARK 500 GLU H 217 70.81 -109.70 REMARK 500 ARG H 244 76.48 -103.14 REMARK 500 LEU H 245 -157.72 -116.87 REMARK 500 ASN I 52 -143.11 -138.37 REMARK 500 ASP I 55 140.88 -5.47 REMARK 500 PRO I 60 103.17 -53.56 REMARK 500 GLU I 61 21.60 -60.46 REMARK 500 ALA M 1B -63.53 60.34 REMARK 500 PHE M 7 -75.47 -137.60 REMARK 500 LYS M 9 50.88 -90.31 REMARK 500 LYS M 10 1.52 -161.25 REMARK 500 THR M 14B 25.23 -142.86 REMARK 500 LYS F 36 -82.26 -49.35 REMARK 500 SER F 48 172.98 177.84 REMARK 500 HIS F 57 -4.79 -47.08 REMARK 500 TYR F 60A 82.23 -166.23 REMARK 500 ASN F 60G 76.83 -170.94 REMARK 500 VAL F 61 -38.67 -36.08 REMARK 500 HIS F 71 -42.40 -136.20 REMARK 500 ARG F 77A -28.64 -29.21 REMARK 500 LYS F 87 123.83 84.45 REMARK 500 ASN F 95 74.60 -103.61 REMARK 500 ASN F 98 16.44 -160.37 REMARK 500 REMARK 500 THIS ENTRY HAS 70 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 CHYMOTRYPSINOGEN NUMBERING (RATHER THAN SEQUENTIAL) SYSTEM REMARK 999 IS USED FOR THROMBIN, BASED ON THE TOPOLOGICAL ALIGNMENT REMARK 999 WITH THE STRUCTURE OF CHYMOTRYPSINOGEN (H. BRANDSTETTER ET REMARK 999 AL., 1992, J. MOL. BIOL., V. 226, 1085). THE NUMBERING REMARK 999 FOR THE PEPTIDE CORRESPONDS TO THE C-TERMINAL RESIDUES OF REMARK 999 HIRUDIN. DBREF 1VIT L 1U 15 UNP P00735 THRB_BOVIN 318 366 DBREF 1VIT H 16 247 UNP P00735 THRB_BOVIN 367 625 DBREF 1VIT I 51 65 UNP P28507 ITHG_HIRME 51 65 DBREF 1VIT M 1U 15 UNP P00735 THRB_BOVIN 318 366 DBREF 1VIT F 16 149A UNP P00735 THRB_BOVIN 367 516 DBREF 1VIT G 149B 247 UNP P00735 THRB_BOVIN 517 625 DBREF 1VIT J 51 65 UNP P28507 ITHG_HIRME 51 65 SEQRES 1 L 49 THR SER GLU ASP HIS PHE GLN PRO PHE PHE ASN GLU LYS SEQRES 2 L 49 THR PHE GLY ALA GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 3 L 49 LEU PHE GLU LYS LYS GLN VAL GLN ASP GLN THR GLU LYS SEQRES 4 L 49 GLU LEU PHE GLU SER TYR ILE GLU GLY ARG SEQRES 1 H 259 ILE VAL GLU GLY GLN ASP ALA GLU VAL GLY LEU SER PRO SEQRES 2 H 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 H 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 H 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 H 259 ASN PHE THR VAL ASP ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 H 259 HIS SER ARG THR ARG TYR GLU ARG LYS VAL GLU LYS ILE SEQRES 7 H 259 SER MET LEU ASP LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 H 259 TRP LYS GLU ASN LEU ASP ARG ASP ILE ALA LEU LEU LYS SEQRES 9 H 259 LEU LYS ARG PRO ILE GLU LEU SER ASP TYR ILE HIS PRO SEQRES 10 H 259 VAL CYS LEU PRO ASP LYS GLN THR ALA ALA LYS LEU LEU SEQRES 11 H 259 HIS ALA GLY PHE LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 H 259 ARG ARG GLU THR TRP THR THR SER VAL ALA GLU VAL GLN SEQRES 13 H 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO LEU VAL GLU SEQRES 14 H 259 ARG PRO VAL CYS LYS ALA SER THR ARG ILE ARG ILE THR SEQRES 15 H 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO GLY GLU GLY SEQRES 16 H 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 H 259 PHE VAL MET LYS SER PRO TYR ASN ASN ARG TRP TYR GLN SEQRES 18 H 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 H 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 H 259 LYS TRP ILE GLN LYS VAL ILE ASP ARG LEU GLY SER SEQRES 1 I 15 HIS ASN ASP GLY ASP PHE GLU GLU ILE PRO GLU GLU TYR SEQRES 2 I 15 LEU GLN SEQRES 1 M 49 THR SER GLU ASP HIS PHE GLN PRO PHE PHE ASN GLU LYS SEQRES 2 M 49 THR PHE GLY ALA GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 3 M 49 LEU PHE GLU LYS LYS GLN VAL GLN ASP GLN THR GLU LYS SEQRES 4 M 49 GLU LEU PHE GLU SER TYR ILE GLU GLY ARG SEQRES 1 F 150 ILE VAL GLU GLY GLN ASP ALA GLU VAL GLY LEU SER PRO SEQRES 2 F 150 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 F 150 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 F 150 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 F 150 ASN PHE THR VAL ASP ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 F 150 HIS SER ARG THR ARG TYR GLU ARG LYS VAL GLU LYS ILE SEQRES 7 F 150 SER MET LEU ASP LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 F 150 TRP LYS GLU ASN LEU ASP ARG ASP ILE ALA LEU LEU LYS SEQRES 9 F 150 LEU LYS ARG PRO ILE GLU LEU SER ASP TYR ILE HIS PRO SEQRES 10 F 150 VAL CYS LEU PRO ASP LYS GLN THR ALA ALA LYS LEU LEU SEQRES 11 F 150 HIS ALA GLY PHE LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 F 150 ARG ARG GLU THR TRP THR THR SEQRES 1 G 109 SER VAL ALA GLU VAL GLN PRO SER VAL LEU GLN VAL VAL SEQRES 2 G 109 ASN LEU PRO LEU VAL GLU ARG PRO VAL CYS LYS ALA SER SEQRES 3 G 109 THR ARG ILE ARG ILE THR ASP ASN MET PHE CYS ALA GLY SEQRES 4 G 109 TYR LYS PRO GLY GLU GLY LYS ARG GLY ASP ALA CYS GLU SEQRES 5 G 109 GLY ASP SER GLY GLY PRO PHE VAL MET LYS SER PRO TYR SEQRES 6 G 109 ASN ASN ARG TRP TYR GLN MET GLY ILE VAL SER TRP GLY SEQRES 7 G 109 GLU GLY CYS ASP ARG ASP GLY LYS TYR GLY PHE TYR THR SEQRES 8 G 109 HIS VAL PHE ARG LEU LYS LYS TRP ILE GLN LYS VAL ILE SEQRES 9 G 109 ASP ARG LEU GLY SER SEQRES 1 J 15 HIS ASN ASP GLY ASP PHE GLU GLU ILE PRO GLU GLU TYR SEQRES 2 J 15 LEU GLN MODRES 1VIT ASN H 60G ASN GLYCOSYLATION SITE MODRES 1VIT ASN F 60G ASN GLYCOSYLATION SITE HET NAG A 1 14 HET NAG A 2 14 HET NAG F 501 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 8 NAG 3(C8 H15 N O6) HELIX 1 1 GLU L 8 LYS L 10 5 3 HELIX 2 2 GLU L 14C SER L 14I 1 7 HELIX 3 3 ALA H 56 CYS H 58 5 3 HELIX 4 4 LYS H 126 LEU H 129C 1 7 HELIX 5 5 ARG H 165 LYS H 169 1 5 HELIX 6 6 PHE H 232 ILE H 242 5 11 HELIX 7 7 GLU M 8 LYS M 10 5 3 HELIX 8 8 LYS M 14D TYR M 14J 1 7 HELIX 9 9 ALA F 56 CYS F 58 5 3 HELIX 10 10 PRO F 60B TRP F 60D 5 3 HELIX 11 11 VAL F 61 ASP F 63 5 3 HELIX 12 12 THR F 128 LYS F 129B 1 4 HELIX 13 13 ARG G 165 SER G 171 1 7 HELIX 14 14 PHE G 232 ILE G 242 5 11 SHEET 1 A 4 LYS H 81 SER H 83 0 SHEET 2 A 4 LEU H 64 ILE H 68 -1 N ILE H 68 O LYS H 81 SHEET 3 A 4 GLN H 30 ARG H 35 -1 N PHE H 34 O LEU H 65 SHEET 4 A 4 LEU H 40 SER H 45 -1 N ALA H 44 O VAL H 31 SHEET 1 B 3 TRP H 51 THR H 54 0 SHEET 2 B 3 ALA H 104 LYS H 107 -1 N LEU H 106 O VAL H 52 SHEET 3 B 3 ILE H 88 ILE H 90 -1 N TYR H 89 O LEU H 105 SHEET 1 C 2 LYS H 135 THR H 139 0 SHEET 2 C 2 VAL H 157 PRO H 161 -1 N LEU H 160 O GLY H 136 SHEET 1 D 4 MET H 180 ALA H 183 0 SHEET 2 D 4 GLY H 226 HIS H 230 -1 N TYR H 228 O PHE H 181 SHEET 3 D 4 TRP H 207 GLY H 216 -1 N TRP H 215 O PHE H 227 SHEET 4 D 4 PRO H 198 LYS H 202 -1 N MET H 201 O TYR H 208 SHEET 1 E 4 LYS F 81 MET F 84 0 SHEET 2 E 4 LEU F 64 ILE F 68 -1 N ILE F 68 O LYS F 81 SHEET 3 E 4 VAL F 31 ARG F 35 -1 N PHE F 34 O LEU F 65 SHEET 4 E 4 GLU F 39 ALA F 44 -1 N ALA F 44 O VAL F 31 SHEET 1 F 3 TRP F 51 THR F 54 0 SHEET 2 F 3 ALA F 104 LYS F 107 -1 N LEU F 106 O VAL F 52 SHEET 3 F 3 ILE F 88 ILE F 90 -1 N TYR F 89 O LEU F 105 SHEET 1 G 2 LYS F 135 GLY F 140 0 SHEET 2 G 2 GLN G 156 PRO G 161 -1 N LEU G 160 O GLY F 136 SHEET 1 H 4 MET G 180 ALA G 183 0 SHEET 2 H 4 GLY G 226 HIS G 230 -1 N TYR G 228 O PHE G 181 SHEET 3 H 4 TRP G 207 GLY G 216 -1 N TRP G 215 O PHE G 227 SHEET 4 H 4 PRO G 198 LYS G 202 -1 N MET G 201 O TYR G 208 SSBOND 1 CYS L 1 CYS H 122 1555 1555 2.04 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.03 SSBOND 3 CYS H 168 CYS H 182 1555 1555 2.04 SSBOND 4 CYS H 191 CYS H 220 1555 1555 2.03 SSBOND 5 CYS M 1 CYS F 122 1555 1555 2.04 SSBOND 6 CYS F 42 CYS F 58 1555 1555 2.04 SSBOND 7 CYS G 168 CYS G 182 1555 1555 2.02 SSBOND 8 CYS G 191 CYS G 220 1555 1555 2.02 LINK ND2 ASN H 60G C1 NAG A 1 1555 1555 1.46 LINK ND2 ASN F 60G C1 NAG F 501 1555 1555 1.46 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.39 CISPEP 1 SER H 36A PRO H 37 0 0.06 CISPEP 2 SER F 36A PRO F 37 0 -0.06 CRYST1 116.400 116.400 200.600 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008591 0.004960 0.000000 0.00000 SCALE2 0.000000 0.009920 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004985 0.00000